Despite the lack of biomarkers that predict development of DS, Shibakura et al. observed that serum levels of IL-8 were increased during the course of ATRA treatment in two patients who developed APL-DS [15]. The gene discussed is CXCL8; the disease is acute promyelocytic leukemia.